DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Astaxanthin is an investigational drug.
There have been 4 clinical trials for Astaxanthin. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2011.
The most common disease conditions in clinical trials are Stroke, Hypercholesterolemia, and Retinal Diseases. The leading clinical trial sponsors are Indonesia University, University Hospital of Ferrara, and Sheba Medical Center.
There is one US patent protecting this investigational drug and twelve international patents.
Recent Clinical Trials for Astaxanthin
|Nutraceutical in Cardiovascular Primary Prevention||University Hospital of Ferrara||Phase 2|
|Physiological and Molecular Influences of Astaxanthin Supplementation on Heat Strain in Humans||Sheba Medical Center||N/A|
|Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy||Instituto Mexicano del Seguro Social||Phase 2|
Top disease conditions for Astaxanthin
Top clinical trial sponsors for Astaxanthin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Astaxanthin||Start Trial||Method for increasing the health condition of crustaceans in aquaculture, survival rate and pigmentation||Start Trial|
|Astaxanthin||Start Trial||Ready-to-use, stable emulsion||BASF SE (Ludwigshafen am Rhein, DE)||Start Trial|
|Astaxanthin||Start Trial||Seaweed-derived cosmetic compositions||Skinergistics Clinical Skin Solutions Inc. (Vancouver, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|